1YYE image
Deposition Date 2005-02-24
Release Date 2006-02-28
Last Version Date 2024-04-03
Entry Detail
PDB ID:
1YYE
Keywords:
Title:
Crystal structure of estrogen receptor beta complexed with way-202196
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
(Taxon ID: )
Method Details:
Experimental Method:
Resolution:
2.03 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Estrogen receptor beta
Chain IDs:A, B
Chain Length:268
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:STEROID RECEPTOR COACTIVATOR-1
Chain IDs:C, D
Chain Length:13
Number of Molecules:2
Biological Source:
Ligand Molecules
Primary Citation
ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity
J.Med.Chem. 48 3953 3979 (2005)
PMID: 15943471 DOI: 10.1021/jm058173s

Abstact

The 2-phenylnaphthalene scaffold was explored as a simplified version of genistein in order to identify ER selective ligands. With the aid of docking studies, positions 1, 4, and 8 of the 2-phenylnaphthalene template were predicted to be the most potentially influential positions to enhance ER selectivity using two different binding orientations. Both orientations have the phenol moiety mimicking the A-ring of genistein. Several compounds predicted to adopt orientations similar to that of genistein when bound to ERbeta were observed to have slightly higher ER affinity and selectivity than genistein. The second orientation we exploited, which was different from that of genistein when bound to ERbeta, resulted in the discovery of several compounds that had superior ER selectivity and affinity versus genistein. X-ray structures of two ER selective compounds (i.e., 15 and 47) confirmed the alternate binding mode and suggested that substituents at positions 1 and 8 were responsible for inducing selectivity. One compound (i.e., 47, WAY-202196) was further examined and found to be effective in two models of inflammation, suggesting that targeting ER may be therapeutically useful in treating certain chronic inflammatory diseases.

Legend

Protein

Chemical

Disease

Primary Citation of related structures